Skip to main content
. 2020 Apr 17;10:545. doi: 10.3389/fonc.2020.00545

Figure 4.

Figure 4

Depletion of FOXK1 attenuates xenograft tumor growth in vivo. (A,B) Representative images of sacrificed nude mice (A) and xenograft tumors (B) derived from subcutaneous implantation of NOZ cells treated with Lv-shFOXK1 or Lv-shNC. (C) Tumor growth curves in different group were calculated in a 4-week course (*P < 0.05, **P < 0.01, and ***P < 0.001). (D) Comparison of tumor weight between shFOXK1 group and shNC group (*P < 0.05, **P < 0.01, and ***P < 0.001). (E) Paraffin sections were stained for IHC with antibodies against ki-67, scale bar =20 μm.